▪ Introduction

Primotex 100 by Novotex Pharma contains Metenolone Enanthate, an injectable anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT) and originally developed for clinical use in muscle-wasting conditions, osteoporosis, and anemia. Metenolone Enanthate is valued for its mild androgenic profile and moderate anabolic activity, making it a focus of laboratory studies on lean mass support, nitrogen retention, and minimal estrogenic side effects.

Manufactured under pharmaceutical-grade conditions, Primotex 100 ensures each ampoule delivers a precise 100 mg/mL concentration of Metenolone Enanthate in a sterile, oil-based solution. Packaged as 10 × 1 mL glass ampoules, this product is intended exclusively for analytical and laboratory use, where dosing accuracy and compound integrity are critical.

▪ Product Details (Bulleted)

• Active Ingredient: Metenolone Enanthate

• Concentration: 100 mg per mL

• Form: Injectable oil-based solution

• Container Type: Glass ampoules

• Pack Size: 10 ampoules × 1 mL per pack

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Metenolone Enanthate exhibits a half-life of approximately 10–14 days following intramuscular administration, allowing for weekly dosing schedules in research protocols. The enanthate ester slows release into circulation, producing stable plasma concentrations and prolonged anabolic activity. It does not aromatize into estrogen, minimizing estrogen-related side effects such as water retention and gynecomastia. Its favorable anabolic-to-androgenic ratio promotes protein synthesis and nitrogen retention while reducing androgenic effects on sensitive tissues.

▪ Usage Recommendations

• Historic Clinical Dosage: Typically 100–200 mg once weekly, adjusted per study design under professional supervision.

• Current Research Use: Intended for controlled laboratory investigations into anabolic mechanisms, lean tissue preservation, and metabolic regulation. Administer intramuscularly at 100 mg/mL once per week unless specified otherwise by the experimental protocol.

• Administration: Intramuscular injection. Use aseptic technique; if dilution is required, follow specific laboratory protocols to maintain concentration accuracy.

• Use Statement: Strictly for laboratory and analytical use only.

▪ Disclaimer

This product is strictly for analytical and laboratory research. It is not approved for human therapeutic use or consumption. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with serious health conditions. Always comply with local regulations, institutional guidelines, and professional research standards when handling and administering Metenolone Enanthate.